India, Oct. 16 -- Sundar Pichai announced an "exciting milestone" regarding DeepMind's Gemma, an AI model that helped discover a new potential cancer therapy pathway. The tech giant developed the new cancer-therapy hypothesis in a research collaboration with Yale University.

"An exciting milestone for AI in science: Our C2S-Scale 27B foundation model, built with Yale and based on Gemma, generated a novel hypothesis about cancer cellular behavior, which scientists experimentally validated in living cells," the tech CEO tweeted.

"With more preclinical and clinical tests, this discovery may reveal a promising new pathway for developing therapies to fight cancer," he added.

The post, which has received millions of views, has prompted sever...